A new company under financial investment firm SOL Partnership has launched what could be the first at-home gut health test service powered by AI in Malaysia.
SpaceGut offers an at-home gut microbiome kit and a laboratory service that provides personalised recommendations for an individual's gut health. Leveraging a proprietary AI, its laboratory evaluates samples compared against a database of...
Lunit collabs with AstraZeneca, secures major deal in France
Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims to accelerate the time-consuming process of genomic testing as part of NSCLC identification and diagnosis by leveraging Lunit's AI. The latter's...
A consortium of research institutes in South Korea has been formed to promote the utilisation of AI and national supercomputers in discovering novel drugs for treating lung cancer.
According to a press statement, the following organisations will collaborate to develop and test AI for identifying novel drug candidates and predicting its efficacy:
DAAN Cancer Research Institute under Yonsei...
ImpriMed, a precision medicine company, announced that it has expanded its services to include human oncology.
The aim is to provide drug-response predictions for routine blood cancers such as newly diagnosed multiple myeloma and acute myeloid leukemia.
ImpriMed's human precision medicine services will set their sights on complex blood cancers via a combination of genomic analysis, ex vivo drug...
Hackensack Meridian Health announced it launched a cancer risk and early detection program at the health system’s Hennessy Institute for Cancer Prevention and Applied Molecular Medicine in partnership with oncology-focused precision health technology company CancerIQ, aimed at improving early diagnosis, treatment and prevention.
The program integrates advanced technology, genomics and AI into...
AIRS Medical bags $20M to take more global markets
Korean medical AI company AIRS Medical has raked in $20 million in a Series C funding round led by BSK Investment and Shinyoung Securities.
Based on a press statement, the company will use its fresh funds to continue its global expansion and invest in R&D.
Last year, AIRS Medical launched its flagship product, SwiftMR, in the United States...
Funding worth A$6.5 million ($4 million) has been awarded to four genomics-focused research projects led by researchers from the University of Melbourne.
These include a project that will establish a patient dataset of inherited retinal diseases; a rapid multi-omic liquid biopsy blood test using whole genome sequencing; research using next-generation sequencing to develop new solutions to...
Boston-based brain-computer interface technology company Neurable announced a partnership with Canadian precision health company Healthspan Digital to offer its neurotechnology to health and longevity clinics to help providers assess cognitive performance and brain health.
Brain-computer interfaces collect brain signals and translate them into commands that are then relayed to external devices,...
Medical Microinstruments, a surgical robotics company, announced it secured $110 million in a Series C financing round led by Fidelity Management & Research Company, with participation from existing investors.
The company offers its Symani Surgical System, a robotic technology for microsurgery and supermicrosurgery. The system allows surgeons to replicate the movement of a human hand at a...
Samsung to integrate Lunit's AI in premium X-ray devices
South Korean medical AI provider Lunit has signed a three-year supply contract with Samsung Electronics.
The deal is for the integration of Lunit's two chest X-ray AI solutions – Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage – into Samsung's line of premium X-ray devices.
According to a press release, the AI-integrated X-ray devices will...
